Dyne Therapeutics (DYN) PT Lowered to $27 at Piper Sandler
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $16.51 +1.73%
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff lowered the price target on Dyne Therapeutics (NASDAQ: DYN) to $27.00 (from $29.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Okta, Inc (OKTA) PT Raised to $235 at DA Davidson Following Oktane 2026
- Everpure (P) PT Raised to $140 at Raymond James
- UiPath Inc. (PATH) PT Lowered to $15 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
